CSF diagnosis of Alzheimer’s disease and dementia with Lewy bodies

被引：0
|
作者：
M. Bibl
B. Mollenhauer
H. Esselmann
P. Lewczuk
C. Trenkwalder
P. Brechlin
E. Rüther
J. Kornhuber
M. Otto
J. Wiltfang
机构：
[1] University of Goettingen,Department of Psychiatry
[2] Harvard Medical School,Brigham and Women’s Hospital, Center for Neurologic Diseases
[3] University of Erlangen-Nuremberg,Department of Psychiatry and Psychotherapy
[4] University of Goettingen,Department of Neurology
[5] University of Ulm,undefined
来源：
Journal of Neural Transmission | 2006年 / 113卷
关键词：
Keywords: Alzheimer’s dementia, Lewy-body dementia, cerebrospinal fluid, amyloid-β peptides, tau protein, biomarker;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
Differential diagnosis of Alzheimer’s disease (AD) and dementia with Lewy bodies (DLB) is often crucial. CSF Tau protein and Amyloid-beta (Aβ) peptides have shown diagnostic value for the diagnosis of AD, but discrimination from DLB was poor.
引用
收藏
页码：1771 / 1778
页数：7
相关论文
共 50 条
  • [1] CSF diagnosis of Alzheimer's disease and dementia with Lewy bodies
    Bibl, M.
    Mollenhauer, B.
    Esselmann, H.
    Lewczuk, P.
    Trenkwalder, C.
    Brechlin, P.
    Ruether, E.
    Kornhuber, J.
    Otto, M.
    Wiltfang, J.
    [J]. JOURNAL OF NEURAL TRANSMISSION, 2006, 113 (11) : 1771 - 1778
  • [2] CSF α-synuclein levels in dementia with Lewy bodies and Alzheimer's disease
    Noguchi-Shinohara, Moeko
    Tokuda, Takahiko
    Yoshita, Mitsuhiro
    Kasai, Takashi
    Ono, Kenjiro
    Nakagawa, Masanori
    El-Agnaf, Omar M. A.
    Yamada, Masahito
    [J]. BRAIN RESEARCH, 2009, 1251 : 1 - 6
  • [3] CSF biomarkers differentiate dementia with Lewy bodies from Alzheimer's disease
    Aerts, M. B.
    Abdo, W. F.
    Esselink, R. A.
    Claassen, J. A.
    Bloem, B. R.
    [J]. MOVEMENT DISORDERS, 2011, 26 : S321 - S322
  • [4] Plasma and CSF serpins in Alzheimer disease and dementia with Lewy bodies
    Nielsen, H. M.
    Minthon, L.
    Londos, E.
    Blennow, K.
    Miranda, E.
    Perez, J.
    Crowther, D. C.
    Lomas, D. A.
    Janciauskiene, S. M.
    [J]. NEUROLOGY, 2007, 69 (16) : 1569 - 1579
  • [5] Dysautonomia in the differential diagnosis of Dementia with Lewy Bodies and Alzheimer's Disease
    Bernardes, C.
    Faustino, P.
    Lima, M.
    Duro, D.
    Duraes, J.
    Baldeiras, I.
    Tabuas-Pereira, M.
    Santana, I.
    [J]. EUROPEAN JOURNAL OF NEUROLOGY, 2023, 30 : 330 - 331
  • [6] CSF amyloid-β-peptides in Alzheimer's disease, dementia with Lewy bodies and Parkinson's disease dementia
    Bibl, M
    Mollenhauer, B
    Esselmann, H
    Lewczuk, P
    Klafki, HW
    Sparbier, K
    Smirnov, A
    Cepek, L
    Trenkwalder, C
    Rüther, E
    Kornhuber, J
    Otto, M
    Wiltfang, J
    [J]. BRAIN, 2006, 129 : 1177 - 1187
  • [7] Dementia with Lewy bodies and Alzheimer's disease
    Rosenberg, CK
    Cummings, TJ
    Saunders, AM
    Widico, C
    McIntyre, LM
    Hulette, CM
    [J]. ACTA NEUROPATHOLOGICA, 2001, 102 (06) : 621 - 626
  • [8] Dementia with Lewy bodies and Alzheimer's disease
    Carlyn K. Rosenberg
    Thomas J. Cummings
    Ann M. Saunders
    Corinne Widico
    Lauren M. McIntyre
    Christine M. Hulette
    [J]. Acta Neuropathologica, 2001, 102 : 621 - 626
  • [9] CSF α-Synuclein Does Not Discriminate Dementia with Lewy Bodies from Alzheimer's Disease
    Reesink, Fransje E.
    Lemstra, Afina W.
    van Dijk, Karin D.
    Berendse, Henk W.
    van de Berg, Wilma D. J.
    Klein, Martin
    Blankenstein, Marinus A.
    Scheltens, Philip
    Verbeek, Marcel M.
    van der Flier, Wiesje M.
    [J]. JOURNAL OF ALZHEIMERS DISEASE, 2010, 22 (01) : 87 - 95
  • [10] CSF Amyloid-β Peptides in Neuropathologically Diagnosed Dementia with Lewy Bodies and Alzheimer's Disease
    Mollenhauer, Brit
    Esselmann, Herrmann
    Trenkwalder, Claudia
    Schulz-Schaeffer, Walter
    Kretzschmar, Hans
    Otto, Markus
    Wiltfang, Jens
    Bibl, Mirko
    [J]. JOURNAL OF ALZHEIMERS DISEASE, 2011, 24 (02) : 383 - 391
12345